Tygacil 50 mg/5mL

Tygacil 50 mg/5mL is a lyophilized powder for injection, used for intravenous administration. It contains tigeycline, an antibiotic indicated for treating certain bacterial infections. This product is manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Tygacil 50 mg/5mL is primarily used for the treatment of complicated skin and skin structure infections, as well as intra-abdominal infections caused by susceptible bacteria. It is often prescribed when other antibiotics are not effective. Tigeycline, the active ingredient, works by inhibiting bacterial growth, making it useful in managing severe infections.

Common effects of Tygacil 50 mg/5mL may include nausea, vomiting, and diarrhea. Some patients might experience headache or dizziness. Severe side effects are rare but can occur, and any unusual symptoms should be reported to a healthcare provider immediately.

Tygacil 50 mg/5mL should be handled with care, ensuring proper reconstitution and administration. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients with known allergies to tigeycline or similar antibiotics should avoid using this medication.

Tygacil 50 mg/5mL may interact with other medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also interact with tigeycline, so caution is advised.